Mark Faesen

Johannesburg, GT, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Efficacy of Combination Treatment for Cervical Precancer Among Women Living with HIV in South Africa: Secondary Outcomes from the ACT 2 Randomized Controlled Trial.

Efficacy of Combination Treatment for Cervical Precancer Among Women Living with HIV in South Africa: Secondary Outcomes from the ACT 2 Randomized Controlled Trial.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among Women Living with HIV in South Africa: Primary Outcomes from the ACT 2 Randomized Trial.

Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among Women Living with HIV in South Africa: Primary Outcomes from the ACT 2 Randomized Trial.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

Randomized clinical trial protocol: Acceptability and feasibility of combination treatment for cervical precancer among South African women living with HIV (ACT 2).

Randomized clinical trial protocol: Acceptability and feasibility of combination treatment for cervical precancer among South African women living with HIV (ACT 2).

Journal: Contemporary clinical trials

Published: September 15, 2025

ACT 2 Clinical Trial Design: Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living with HIV.

ACT 2 Clinical Trial Design: Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living with HIV.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2025

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.

Journal: Lancet (London, England)

Published: December 20, 2021

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.

Journal: PLoS medicine

Published: November 26, 2021

Human Papillomavirus Vaccination Prior to Loop Electroexcision Procedure Does Not Prevent Recurrent Cervical High-grade Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus: A Randomized, Double-blind, Placebo-controlled Trial.

Human Papillomavirus Vaccination Prior to Loop Electroexcision Procedure Does Not Prevent Recurrent Cervical High-grade Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus: A Randomized, Double-blind, Placebo-controlled Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 11, 2020

Estimating the burden of cervical disease among HIV-infected women accessing screening services in South Africa: A model-based analysis.

Estimating the burden of cervical disease among HIV-infected women accessing screening services in South Africa: A model-based analysis.

Journal: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Published: February 27, 2018

Cryotherapy Reduces Progression of Cervical Intraepithelial Neoplasia Grade 1 in South African HIV-Infected Women: A Randomized, Controlled Trial.

Cryotherapy Reduces Progression of Cervical Intraepithelial Neoplasia Grade 1 in South African HIV-Infected Women: A Randomized, Controlled Trial.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: September 14, 2017

A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa.

A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa.

Journal: American journal of obstetrics and gynecology

Published: January 12, 2017

Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women.

Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women.

Journal: Papillomavirus research (Amsterdam, Netherlands)

Published: November 18, 2015

Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.

Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.

Journal: PloS one

Published: August 31, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026